In 2005, a DNA microarray analysis on papillary thyroid cancer identified genetic signatures that distinctly correlate with mutations in BRAF, RAS, and RET/PTC papillary thyroid cancers [90]. This evidence concerns the gene RET and thyroid gland papillary carcinoma.